SCHEMBL30762411

SCHEMBL30762411

N#Cc1cc(N2CCOCC2)nc2c(Br)cc(Cl)cc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.54
▸ ATM Q13315 1/20 0.54
▸ L3MBTL1 Q9Y468 1/20 0.54
▸ ATR Q13535 4/20 0.48
▸ ATRIP Q8WXE1 3/20 0.48
▸ MAPK1 P28482 1/20 0.46
▸ KMT2A Q03164 3/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ PIK3CA P42336 2/20 0.43
▸ MAPT P10636 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ POLB P06746 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.39
▸ NSD2 O96028 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ CASP1 P29466 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30762583 0.88 CNR1 (0.40) HTTATML3MBTL1ATRATRIP
SCHEMBL30762663 0.85 HTT (0.54) HTTATML3MBTL1ATRATRIP
SCHEMBL30762530 0.81 HTT (0.49) HTTATML3MBTL1ATRATRIP
SCHEMBL30762537 0.81 HTT (0.49) HTTATML3MBTL1ATRATRIP
SCHEMBL30762375 0.81 HTT (0.49) HTTATML3MBTL1ATRATRIP
SCHEMBL23110061 0.80 HTT (0.70) HTTATML3MBTL1ATRATRIP
SCHEMBL30762523 0.76 ALDH1A1 (0.49) HTTL3MBTL1MAPK1KMT2AMEN1
SCHEMBL30762689 0.74 PTGES (0.36) —
SCHEMBL30762373 0.73 KDM4E (0.46) HTTATML3MBTL1ATRATRIP
SCHEMBL30762620 0.72 KDM4E (0.45) HTTATML3MBTL1MAPK1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024026423-A1 SUBSTITUTED QUINOLINE DERIVATIVES AS PI3K INHIBITORS BLACK DIAMOND THERAPEUTICS, INC. (US) 2024-02-01 — — WO disclosed
Send feedback